Geumsan Black Ginseng Co. Ltd.

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Geumsan Black Ginseng Co. Ltd.

Is Geumsan Black Ginseng Co. Ltd. on an FDA import alert?

No listing for Geumsan Black Ginseng Co. Ltd. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the South Korea page.

Has FDA refused shipments from Geumsan Black Ginseng Co. Ltd.?

Yes. FDA refused 1 shipment line from Geumsan Black Ginseng Co. Ltd. on January 20, 2026. The most recent, on January 20, 2026, was ginseng (herbal & botanicals, not teas), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Geumsan Black Ginseng Co. Ltd.'s shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).

When was Geumsan Black Ginseng Co. Ltd. last inspected by FDA?

FDA's most recent inspection of Geumsan Black Ginseng Co. Ltd. with a final classification is dated August 22, 2024 and was classified VAI (Voluntary Action Indicated).

What is Geumsan Black Ginseng Co. Ltd.'s FEI number?

Geumsan Black Ginseng Co. Ltd.'s FDA Establishment Identifier (FEI) is 3013599282.